FDA approves AstraZeneca’s Farxiga for treating type 2 diabetes

FDA approves AstraZeneca’s Farxiga for treating type 2 diabetes

Published: Just now By Nikita Chaurasia

Type-2 diabetes is classified as a chronic condition that impacts the body’s way of processing blood sugar or glucose. Currently, the condition can be regulated using exercise, diet, insulin therapy and medication.....

Hyundai plans to raise stake in China’s Sichuan Hyundai Motor

Hyundai Motor Company identifies the significance and impact of automobiles, and strives to fulfill its goals by creating new and advanced vehicles that addresses all the vital issues faced by drivers. The automobile giant has effectiv....

TransPerfect expands its portfolio by acquiring Sublime Subtitling

With decades of hard work and hands-on experience, TransPerfect has managed to become one of the largest global providers of technology and language solutions for companies worldwide. With over 5,000 global organizations employing its Globa....

Altran to launch a Digital Therapeutics Innovation Center in Boston

Digital therapeutics are evidence-based interventions conducted by advanced software programs to manage, treat or prevent clinical disorders. Its adoption has augmented the whole medical industry, making it simpler for practi....

Eli Lilly’s Phase 3 SEQUOIA trial fails to meet primary endpoint

Metastatic pancreatic cancer (MPC) is one of the most fatal cancers in the world. Pancreatic cancer is slated to be the third leading cause of cancer death in the U.S. and is expected to become the second leading cause of cancer-related dea....

Replimune gives an update on RP1 Clinical Development Program in CSCC

Cutaneous squamous cell carcinoma (CSCC) is the second most common form of skin cancer caused because of the uncontrolled growth of abnormal squamous cells. Currently, Libtayo is the only approved treatment in the Brazil and United States, ....

Kyowa Kirin’s NOURIANZ™ bags FDA nod for sale in the U.S.

Parkinson’s Disease is a progressive nervous system disorder that hampers the movement of the body by causing stiffness or slowness. Currently there are no definitive treatments for this clinical condition. However, various ....